Background: LCZ696 is a novel neuroendocrine inhibitor that has been widely used in heart failure (HF). However, its advantage over other neuroendocrine inhibitors, such as angiotensin-converting enzyme inhibitors (ACEis) and angiotensin-receptor blockers (ARBs) has not been fully elucidated. This study aimed to provide the latest evidence regarding the efficacy and safety of LCZ696 as compared to other ACEis and ARBs with regards to the treatment of HF.
View Article and Find Full Text PDFJ Chromatogr B Analyt Technol Biomed Life Sci
September 2020
The increased attention to luminescent copper(I) complexes, mostly mononuclear and dinuclear ones, in the past few years was mainly due to the new pathways established in the intersystem crossing (ISC) for highly efficient singlet/triplet harvesting, which showed great potential in light-emitting devices. Governing the photophysical processes of planar cyclic trinuclear complexes is more challenging owing to the rich intra- and intermolecular metal-metal interactions involved, but new opportunities also accompany this. Herein reported is a hidden route to the ultra-long-lived, highly efficient phosphorescence of cyclic trinuclear two-coordinate Cu-pyrazolate complexes through pushing the unfavorable metal-to-ligand charge transfer events to the high-lying ISC pathways.
View Article and Find Full Text PDF